Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 13.02.26
Ensuring equal access to early cancer detection and treatment in Slovenia (Guest blog)
Slovenia marked World Cancer Day with its 6th Strategic Conference Living with Cancer, held at the National Council of the Republic of Slovenia - a venue...
Read Article -
Statements & press releases 09.02.26
Digital Medicines Information gains momentum
A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information (ePI) pilot projects across...
Read Article -
Statements & press releases 09.02.26
European pharmaceuticals key to strengthening EU competitiveness
Without the pharmaceutical industry the EU trade balance would go from a surplus of €147 billion to a €47 billion deficit
Read Article -
External Event 19.03.26
J&J | The essentials of partnering with a pharma company
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation to patients.
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event -
EFPIA Event 21.04.26
Europe’s Choice: Investing in sustainable health systems
Amid ageing populations, rising non-communicable diseases and pressure on health systems, this high-level conference will examine how prevention, early...
View Event